Abstract
To the Editor: TNP-470 is a new inhibitor of angiogenesis that has shown potent antitumor activity in preclinical studies.1–4 We performed a phase 1 study of this drug in patients with advanced squ...
Cite
CITATION STYLE
APA
Kudelka, A. P., Verschraegen, C. F., & Loyer, E. (1998). Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470. New England Journal of Medicine, 338(14), 991–992. https://doi.org/10.1056/nejm199804023381412
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free